Clinical trial
A Phase 2, Randomized, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of PRAX-114 in Participants With Post-Traumatic Stress Disorder
NCT05260541 is registered in ClinicalTrials.gov with Praxis Precision Medicines as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 2, Randomized, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of PRAX-114 in Participants With Post-Traumatic Stress Disorder
- Lead sponsor
- Praxis Precision Medicines
- Phase
- Phase 2
- Overall status
- Terminated
- Start date
- January 25, 2022
- Completion date
- September 23, 2022
- Enrollment
- 11 (actual)
- Sites
- 17
Conditions
As the registry lists them; a condition with its own page is linked.
mental disorder, post traumatic stress disorder, post-traumatic stress disorder, stress disorder, stress disorders, post-traumatic, trauma and stressor related disorders